Please login to the form below

Not currently logged in
Email:
Password:

opioid abuse

This page shows the latest opioid abuse news and features for those working in and with pharma, biotech and healthcare.

Heron boosted by new data for ‘breakthrough’ pain drug

Heron boosted by new data for ‘breakthrough’ pain drug

opioid analgesics compared to both placebo and local anaesthesia monotherapy with bupivacaine in the first 48 hours after surgery. ... The reduction in opioid use is another important facet of the new therapy, given the US’s current epidemic of opioid

Latest news

  • FDA panel backs Indivior’s drug to fight opioid addiction FDA panel backs Indivior’s drug to fight opioid addiction

    naloxone), another treatment for opioid dependence, and which raised the threat of low-cost copies reaching the market earlier than expected. ... Opioid abuse has become such an acute problem in the US that President Trump signed an executive order last

  • FDA approves first substance use mobile medical application FDA approves first substance use mobile medical application

    Reset works by teaching users skills to increase their abstinence from substance abuse and keep them in outpatient therapy programmes. ... The trial did not demonstrate the effectiveness of using Reset for opioid abuse and the application is not licensed

  • Endo faces industry-first FDA call to pull its opioid painkiller Endo faces industry-first FDA call to pull its opioid painkiller

    abuse.”. Opioid overdoses killed 33, 000 Americans in 2015 - with half of those involving a prescription opioid. ... Previously Purdue Pharma’s opioid painkiller Oxycontin was removed from the market when an abuse-resistant form became available, but

  • A rock and a hard place A rock and a hard place

    Without the tamper-resistant packaging, critics argued that the FDA was ignoring the high potential for opioid abuse and the ramifications that came along with that. ... 51. Achievement of narrow targets and the potential for abuse are very different

  • FDA panel backs Pfizer and Teva abuse-resistant painkillers FDA panel backs Pfizer and Teva abuse-resistant painkillers

    FDA panel backs Pfizer and Teva abuse-resistant painkillers. Recommends long-acting opioid analgesics Troxyca ER and Vantrela ER for approval. ... An FDA advisory committee has recommended approval of two long-acting opioid analgesics from Teva and

More from news
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics